(Image credit: quantic69 via Getty Images)
A man with type 1 diabetes has become the first patient to be able to produce his own insulin after receiving a genetically modified cell transplant, without requiring drugs to prevent rejection.
The case, described this month in the New England Journal of Medicine, represents a potential breakthrough in treatment for a disease that affects 9.5 million people worldwide.
Type 1 diabetes occurs when a patient’s immune system destroys specific cells in the pancreas, known as islet cells, which are responsible for producing insulin, a hormone that regulates blood glucose levels. Although the disease can be controlled with regular injections of synthetic insulin, there is no cure.
You may like
-
American child receives first-ever personalized treatment for genetic disease using CRISPR
-
The study found that drugs like Ozempic treat type 1 diabetes, not just type 2.
Sourse: www.livescience.com
